A phase III randomized trial of gantenerumab in prodromal Alzheimer’s disease

Overview of attention for article published in Alzheimer's Research & Therapy, December 2017

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (95th percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

So far, Dimensions has found 394 publications that cite this research output.

Article in Archives of Gerontology and Geriatrics Plus (June 2024)

Article in Ageing Research Reviews (April 2024)

Article in Neurology and Therapy (April 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.